SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682) (NDRA) — Jan 22, 2020

ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682)
Date: Jan. 22, 2020 · CIK: 0001681682 · Accession: 0001654954-20-000666

AI Filing Summary & Sentiment

File numbers found in text: 333-235883

Date
Jan. 22, 2020
Author
/s/
Form
CORRESP
Company
ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682)

Letter

Blueprint

ENDRA Life Sciences Inc.

Green Court, Suite 350

Ann Arbor, MI 48105

January 22, 2020

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Ada D. Sarmento

Re:

ENDRA Life Sciences Inc.

Registration Statement on Form S-3

File No. 333-235883

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant ENDRA Life Sciences Inc. hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 5:00 p.m., Eastern Time, on Thursday, January 23, 2020, or as soon thereafter as is practicable.

Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has been granted.

Sincerely,
/s/
David Wells

Show Raw Text
CORRESP
1
filename1.htm

Blueprint

ENDRA
Life Sciences Inc.

3600
Green Court, Suite 350

Ann
Arbor, MI 48105

January
22, 2020

Securities
and Exchange Commission

100 F
Street, N.E.

Washington,
D.C. 20549

Attention:
Ada D. Sarmento

Re:

ENDRA Life Sciences
Inc.

Registration
Statement on Form S-3

File No.
333-235883

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as
amended, registrant ENDRA Life Sciences Inc. hereby respectfully
requests that the above-referenced Registration Statement on Form
S-3 be declared effective at 5:00 p.m., Eastern Time, on Thursday,
January 23, 2020, or as soon thereafter as is
practicable.

Please
direct any questions regarding this request to Mark Busch of
K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com).
In addition, please notify Mr. Busch when this request for
acceleration has been granted.

Sincerely,

/s/
David Wells

David
Wells

Chief
Financial Officer